Unauthorised compounded semaglutide and tirzepatide formulations

Compounded versions of semaglutide and tirzepatide that emerged in the United States by exploiting legal loopholes during the supply shortage. They are neither authorised nor assessed by the AEMPS or the FDA, and in Spain there is no legal framework whatsoever for their use.

Institutional endorsement by Clínica Evolution

This entry is for information. Your case requires an individual medical assessment.